May 22, 2026

• 2:35 PM · Endpoints News
  2:35 PMFDA clears Gilead's hepatitis D drug, four years after prior rejection — Endpoints News
• 1:50 PM · Endpoints News
  1:50 PMGOP lawmaker asks Trump administration to curb China biotech deals — Endpoints News
• 12:00 PM · BioWorld
  12:00 PMDaewoong takes over Turn Bio’s longevity platform from Hanall — BioWorld
• 12:00 PM · BioWorld
  12:00 PMMEK inhibitor delivers 17.3-month OS for pancreatic cancer — BioWorld
• 12:00 PM · BioWorld
  12:00 PMEMA poised to be 4th regulator approving Boehringer’s Jascayd lung drug — BioWorld
• 11:28 AM · Endpoints News
  11:28 AMFDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approval — Endpoints News
• 9:00 AM · Endpoints News
  9:00 AMNovartis says Avidity's science could apply beyond muscular dystrophies — Endpoints News
• 9:00 AM · BioWorld
  9:00 AMAsgard’s AT-108 shows promise as immunotherapeutic — BioWorld
• 9:00 AM · BioWorld
  9:00 AMSelection Therapeutics identifies new Kv1.3 blockers — BioWorld
• 9:00 AM · BioWorld
  9:00 AMHanmi discloses new YAP1/TEAD interaction inhibitors — BioWorld
• 9:00 AM · BioWorld
  9:00 AMIgnis Therapeutics synthesizes new muscarinic M4 receptor PAMs — BioWorld
• 9:00 AM · BioWorld
  9:00 AMDual-targeting, rapamycin-enhanced CAR T for multiple myeloma — BioWorld
• 9:00 AM · BioWorld
  9:00 AMScribe’s STX-1150 for hypercholesterolemia cleared for clinic — BioWorld
• 9:00 AM · BioWorld
  9:00 AMSangamo presents primate data for prion suppressor ST-506 — BioWorld
• 9:00 AM · BioWorld
  9:00 AMHenlius gains Australian trial clearance for HLX-3902 — BioWorld
• 9:00 AM · BioWorld
  9:00 AMTREM2 agonists detailed in Pfizer patent — BioWorld
• 9:00 AM · BioWorld
  9:00 AMAVB-406: AAV-miRNA targeting MAPT in Alzheimer’s disease — BioWorld
• 9:00 AM · BioWorld
  9:00 AMNew PARP1/2-tankyrase inhibitor bests first-gen PARP inhibitors — BioWorld
• 9:00 AM · BioWorld
  9:00 AMShanghai Maxinovel Pharmaceuticals patents new PD-1/ PD-L1 interaction inhibitors — BioWorld
• 8:50 AM · Pharmaceutical Technology
  8:50 AMCVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati — Pharmaceutical Technology
• 8:27 AM · SCMP — Tech
  8:27 AMFrance to invest €1.5 billion in quantum computing, advanced microchips — SCMP — Tech
• 7:00 AM · Endpoints News
  7:00 AMAmgen CFO to follow David Reese into retirement; Josh Smiley is out at Zai Lab — Endpoints News
• 7:00 AM · STAT News
  7:00 AMSTAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion — STAT News
• 6:19 AM · Pharmaceutical Technology
  6:19 AMGilead Sciences acquires Tubulis for $5bn — Pharmaceutical Technology
• 5:07 AM · Pharmaceutical Technology
  5:07 AMConcept Life Sciences and OpenBench partner on drug discovery services — Pharmaceutical Technology
• 5:00 AM · Drug Discovery World
  5:00 AMHaemaLogiX launches Phase I multiple myeloma trial — Drug Discovery World
• 4:30 AM · STAT News
  4:30 AMSTAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington — STAT News
• 4:00 AM · Drug Discovery World
  4:00 AMCompany shows ‘new therapeutic modality’ at ASGCT 2026 — Drug Discovery World
• 2:01 AM · Bloomberg — Technology
  2:01 AMInsilico on Applying AI to Transform Drug Discovery — Bloomberg — Technology